CTOs on the Move

Mercy Flight Central Inc

www.mercyflightcentral.org

 
Mercy Flight Central Inc is a Canandaigua, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Lernia Training Solutions

Lernia Training Solutions is a Newtown Square, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TCP Reliable

TCP Reliable is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. TCP Reliable is based in Edison, NJ. You can find more information on TCP Reliable at www.tcpreliable.com

Abc For Health

Abc For Health is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CASI Pharmaceuticals

CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.

Questcor

We are a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Our efforts are currently focused on the fields of neurology, nephrology and rheumatology, areas of medicine which have significant unmet medical needs. Our main product is H.P Acthar® Gel (repository corticotropin injection), a naturally-derived formulation of adrenocorticotropic hormones used in a variety of disorders having an inflammatory component. We are currently supporting research in a number of rare conditions, where there is significant unmet need for treatment alternatives to standard therapies. We are also actively supporting research efforts to better understand disease processes and therapeutic mechanisms of action in conditions where Acthar might potentially play a role in treatment.